< Back to latest news & events

Event

LSPN Europe 2022

November 2022

Event date: 29th November 2022

HGF is a silver sponsor of LSPN Europe 2022 on 29th November in London.

This event will explore some of the biggest challenges facing the Life Sciences Patent Community right now and offer insights from leading experts on how to overcome them.

HGF’s Partner & Head of Law Rachel Fetches will be moderating the panel “Collaboration: Private Practice and In-House Counsel Panel Discussion”. 
This panel will cover:

  • What are our most significant current challenges?
  • What do we want from external attorneys?
  • How can the two sides best work together?

HGF’s Partner & Patent Attorney Dr Claire Irvine is hosting a roundtable on “Biologics & Biosimilars” at the event.

Attending the event is HGF’s Legal Director Yael Shalem Givon and HGF’s IP Solicitor Christie Batty.

FIND OUT MORE

Attendees

Christie
Batty

Rachel
Fetches

Latest updates

Seminar on Incorporating Trade Secrets into your IP Strategy

HGF is hosting a Seminar on Incorporating Trade Secrets into your IP Strategy which will be followed by networking, apero, and snacks. The Seminar will be held on Wednesday, 10th …

Read article

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

Regulatory Exclusivity for
Medicinal Products in Europe

Video overview: New Medical Products 8 years of data exclusivity, followed by 2 years of market exclusivity. +1 year market exclusivity possible for a new indication showing significant clinical benefit. No exclusivity granted for new formulations or routes of …

Read article

Added Matter - Part 2

Video overview: Pre- and Post-Grant Amendments are governed by Articles 123(2) & 123(3) EPC respectively Before grant, amendments can broaden the claim scope as long as the resulting claim is …

Read article

Added Matter - Part 1

Video overview: What is Added Matter? Added matter occurs when an amendment introduces content that goes beyond what was originally disclosed in the application as filed (Article 123(2) EPC). EPO …

Read article

Patenting Polymorphs at the EPO

Video overview: Novelty and Inventive Step Prior art must necessarily lead to the claimed polymorph to be novelty destroying Watch out for inherent disclosures in prior art—methods may implicitly produce …

Read article

Antibodies

Video overview: EPO Requirements for Antibody Applications The EPO Guidelines (G-II, 6) provide a standardised framework for antibody-related patent issues. Antibodies can be defined by various aspects, including but not …

Read article

Description Amendment Requirements at EPO

Video overview: At the final stage of prosecution, the EPO increasingly insists each patent description must align with the allowed claims to improve clarity and eliminate inconsistencies. However, this strict …

Read article
See all updates